249 related articles for article (PubMed ID: 11305466)
1. Prospective cohort studies of shigellosis during military field training.
Cohen D; Sela T; Slepon R; Yavzori M; Ambar R; Orr N; Robin G; Shpielberg O; Eldad A; Green M
Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):123-6. PubMed ID: 11305466
[TBL] [Abstract][Full Text] [Related]
2. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.
Cohen D; Green MS; Block C; Rouach T; Ofek I
J Infect Dis; 1988 May; 157(5):1068-71. PubMed ID: 3283258
[No Abstract] [Full Text] [Related]
3. Epidemiological, clinical and microbiological features of shigellosis among hospitalized children in northern Israel.
Admoni O; Yagupsky P; Golan A; Kenes Y; Schifroni G; Horowitz I
Scand J Infect Dis; 1995; 27(2):139-44. PubMed ID: 7660077
[TBL] [Abstract][Full Text] [Related]
4. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.
Cohen D; Ashkenazi S; Green MS; Gdalevich M; Robin G; Slepon R; Yavzori M; Orr N; Block C; Ashkenazi I; Shemer J; Taylor DN; Hale TL; Sadoff JC; Pavliakova D; Schneerson R; Robbins JB
Lancet; 1997 Jan; 349(9046):155-9. PubMed ID: 9111538
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile.
Ferreccio C; Prado V; Ojeda A; Cayyazo M; Abrego P; Guers L; Levine MM
Am J Epidemiol; 1991 Sep; 134(6):614-27. PubMed ID: 1951266
[TBL] [Abstract][Full Text] [Related]
6. Burden and risk factors of Shigella sonnei shigellosis among children aged 0-59 months in hyperendemic communities in Israel.
Cohen D; Korin H; Bassal R; Perry Markovich M; Sivan Y; Goren S; Muhsen K
Int J Infect Dis; 2019 May; 82():117-123. PubMed ID: 30831222
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
[TBL] [Abstract][Full Text] [Related]
8. Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.
Levine MM; Gangarosa EJ; Werner M; Morris GK
J Pediatr; 1974 Jun; 84(6):803-6. PubMed ID: 4596999
[No Abstract] [Full Text] [Related]
9. Clinical trials of Shigella vaccines in Israel.
Cohen D; Ashkenazi S; Green M; Gdalevich M; Yavzori M; Orr N; Robin G; Slepon R; Lerman Y; Block C; Ashkenazi I; Taylor D; Hale L; Sadoff J; Schneerson R; Robbins J; Wiener M; Shemer J
Adv Exp Med Biol; 1996; 397():159-67. PubMed ID: 8718595
[No Abstract] [Full Text] [Related]
10. Short report: High incidence of shigellosis among Peruvian soldiers deployed in the Amazon River basin.
Jones FR; Sanchez JL; Meza R; Batsel TM; Burga R; Canal E; Block K; Perez J; Bautista CT; Escobedo J; Walz SE
Am J Trop Med Hyg; 2004 Jun; 70(6):663-5. PubMed ID: 15211010
[TBL] [Abstract][Full Text] [Related]
11. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
Kotloff KL; Winickoff JP; Ivanoff B; Clemens JD; Swerdlow DL; Sansonetti PJ; Adak GK; Levine MM
Bull World Health Organ; 1999; 77(8):651-66. PubMed ID: 10516787
[TBL] [Abstract][Full Text] [Related]
12. Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns.
Gupta A; Polyak CS; Bishop RD; Sobel J; Mintz ED
Clin Infect Dis; 2004 May; 38(10):1372-7. PubMed ID: 15156473
[TBL] [Abstract][Full Text] [Related]
13. An inverse and independent association between Helicobacter pylori infection and the incidence of shigellosis and other diarrheal diseases.
Cohen D; Shoham O; Orr N; Muhsen K
Clin Infect Dis; 2012 Feb; 54(4):e35-42. PubMed ID: 22157171
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of shigellosis in Israel.
Dan M; Michaeli D; Treistman J
Ann Trop Med Parasitol; 1988 Apr; 82(2):159-62. PubMed ID: 3052334
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of shigellosis among children exposed to cases of Shigella dysentery: a multivariate assessment.
Ahmed F; Clemens JD; Rao MR; Ansaruzzaman M; Haque E
Am J Trop Med Hyg; 1997 Mar; 56(3):258-64. PubMed ID: 9129527
[TBL] [Abstract][Full Text] [Related]
16.
Clarkson KA; Porter CK; Talaat KR; Frenck RW; Alaimo C; Martin P; Bourgeois AL; Kaminski RW
mSphere; 2021 Aug; 6(4):e0012221. PubMed ID: 34259559
[No Abstract] [Full Text] [Related]
17. Recent trends in the epidemiology of Shigella species in Israel.
Ashkenazi S; May-Zahav M; Dinari G; Gabbay U; Zilberberg R; Samra Z
Clin Infect Dis; 1993 Nov; 17(5):897-9. PubMed ID: 8286636
[TBL] [Abstract][Full Text] [Related]
18. A comparison of disease caused by Shigella and Campylobacter species: 24 months community based surveillance in 4 slums of Karachi, Pakistan.
Soofi SB; Habib MA; von Seidlein L; Khan MJ; Muhammad S; Bhutto N; Khan MI; Rasool S; Zafar A; Clemens JD; Nizami Q; Bhutta ZA
J Infect Public Health; 2011 Mar; 4(1):12-21. PubMed ID: 21338955
[TBL] [Abstract][Full Text] [Related]
19. Shigellosis in custodial institutions. V. Effect of intervention with streptomycin-dependent Shigella sonnei vaccine in an institution with endemic disease.
Levine MM; Gangarosa EJ; Barrow WB; Weiss CF
Am J Epidemiol; 1976 Jul; 104(1):88-92. PubMed ID: 779465
[TBL] [Abstract][Full Text] [Related]
20. Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.
Chisenga CC; Bosomprah S; Simuyandi M; Mwila-Kazimbaya K; Chilyabanyama ON; Laban NM; Bialik A; Asato V; Meron-Sudai S; Frankel G; Cohen D; Chilengi R
PLoS One; 2021; 16(5):e0252222. PubMed ID: 34043697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
